A window of opportunity trial evaluating intratumoral injection of Copaxone® in patients with percutaneously accessible tumors.
Saved in:
| Title: | A window of opportunity trial evaluating intratumoral injection of Copaxone® in patients with percutaneously accessible tumors. |
|---|---|
| Authors: | Baranda JC; Clinical Research Center, University of Kansas Comprehensive Cancer Center, Fairway, KS, USA., Mohyuddin GR; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Bur AM; Department of Otolaryngology-Head and Neck Surgery, University of Kansas Medical Center, Kansas City, KS, USA., Shnayder Y; Department of Otolaryngology-Head and Neck Surgery, University of Kansas Medical Center, Kansas City, KS, USA., Sweeney KR; Department of Orthopedic Surgery and Sports Medicine, Sarcoma Center, University of Kansas Comprehensive Cancer Center, Kansas City, KS, USA., Kakarala K; Department of Otolaryngology-Head and Neck Surgery, University of Kansas Medical Center, Kansas City, KS, USA., Prouty M; Department of Dermatology, University of Utah, Salt Lake City, UT, USA., Pathak H; Department of Pathology and Laboratory Medicine, Medical Center, University of Kansas, Kansas City, KS, USA.; Kansas Institute for Precision Medicine, Medical Center, University of Kansas, Kansas City, KS, USA., Puri R; Department of Pathology and Laboratory Medicine, Medical Center, University of Kansas, Kansas City, KS, USA., Mitra A; Department of Pathology and Laboratory Medicine, Medical Center, University of Kansas, Kansas City, KS, USA., Madan R; Department of Pathology and Laboratory Medicine, Medical Center, University of Kansas, Kansas City, KS, USA., Forrest ML; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA., Huang A; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA., Weir S; Institute for Advancing Medical Innovation, Medical Center, University of Kansas, Kansas City, KS, USA., Godwin AK; Department of Pathology and Laboratory Medicine, Medical Center, University of Kansas, Kansas City, KS, USA.; Kansas Institute for Precision Medicine, Medical Center, University of Kansas, Kansas City, KS, USA., Alhakamy NA; Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.; Center of Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, Jeddah, Saudi Arabia.; Mohamed Saeed Tamer Chair for Pharmaceutical Industries, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.; Kinimmune, Inc, St. Louis, MO, USA., Griffin JD; Kinimmune, Inc, St. Louis, MO, USA., Berkland CJ; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA.; Kinimmune, Inc, St. Louis, MO, USA.; Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, KS, USA. |
| Source: | Translational medicine communications [Transl Med Commun] 2023; Vol. 8. Date of Electronic Publication: 2023 Feb 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101738095 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2396-832X (Electronic) Linking ISSN: 2396832X NLM ISO Abbreviation: Transl Med Commun Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40230575 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A window of opportunity trial evaluating intratumoral injection of Copaxone® in patients with percutaneously accessible tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Baranda+JC%22">Baranda JC</searchLink>; Clinical Research Center, University of Kansas Comprehensive Cancer Center, Fairway, KS, USA.<br /><searchLink fieldCode="AU" term="%22Mohyuddin+GR%22">Mohyuddin GR</searchLink>; Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Bur+AM%22">Bur AM</searchLink>; Department of Otolaryngology-Head and Neck Surgery, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Shnayder+Y%22">Shnayder Y</searchLink>; Department of Otolaryngology-Head and Neck Surgery, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Sweeney+KR%22">Sweeney KR</searchLink>; Department of Orthopedic Surgery and Sports Medicine, Sarcoma Center, University of Kansas Comprehensive Cancer Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Kakarala+K%22">Kakarala K</searchLink>; Department of Otolaryngology-Head and Neck Surgery, University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Prouty+M%22">Prouty M</searchLink>; Department of Dermatology, University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Pathak+H%22">Pathak H</searchLink>; Department of Pathology and Laboratory Medicine, Medical Center, University of Kansas, Kansas City, KS, USA.; Kansas Institute for Precision Medicine, Medical Center, University of Kansas, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Puri+R%22">Puri R</searchLink>; Department of Pathology and Laboratory Medicine, Medical Center, University of Kansas, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Mitra+A%22">Mitra A</searchLink>; Department of Pathology and Laboratory Medicine, Medical Center, University of Kansas, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Madan+R%22">Madan R</searchLink>; Department of Pathology and Laboratory Medicine, Medical Center, University of Kansas, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Forrest+ML%22">Forrest ML</searchLink>; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA.<br /><searchLink fieldCode="AU" term="%22Huang+A%22">Huang A</searchLink>; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA.<br /><searchLink fieldCode="AU" term="%22Weir+S%22">Weir S</searchLink>; Institute for Advancing Medical Innovation, Medical Center, University of Kansas, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Godwin+AK%22">Godwin AK</searchLink>; Department of Pathology and Laboratory Medicine, Medical Center, University of Kansas, Kansas City, KS, USA.; Kansas Institute for Precision Medicine, Medical Center, University of Kansas, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Alhakamy+NA%22">Alhakamy NA</searchLink>; Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.; Center of Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, Jeddah, Saudi Arabia.; Mohamed Saeed Tamer Chair for Pharmaceutical Industries, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.; Kinimmune, Inc, St. Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Griffin+JD%22">Griffin JD</searchLink>; Kinimmune, Inc, St. Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Berkland+CJ%22">Berkland CJ</searchLink>; Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA.; Kinimmune, Inc, St. Louis, MO, USA.; Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, KS, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101738095%22">Translational medicine communications</searchLink> [Transl Med Commun] 2023; Vol. 8. <i>Date of Electronic Publication: </i>2023 Feb 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101738095 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2396-832X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222396832X%22">2396832X </searchLink><i>NLM ISO Abbreviation: </i>Transl Med Commun <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40230575 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s41231-023-00137-9 Languages: – Code: eng Text: English Titles: – TitleFull: A window of opportunity trial evaluating intratumoral injection of Copaxone® in patients with percutaneously accessible tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Baranda JC – PersonEntity: Name: NameFull: Mohyuddin GR – PersonEntity: Name: NameFull: Bur AM – PersonEntity: Name: NameFull: Shnayder Y – PersonEntity: Name: NameFull: Sweeney KR – PersonEntity: Name: NameFull: Kakarala K – PersonEntity: Name: NameFull: Prouty M – PersonEntity: Name: NameFull: Pathak H – PersonEntity: Name: NameFull: Puri R – PersonEntity: Name: NameFull: Mitra A – PersonEntity: Name: NameFull: Madan R – PersonEntity: Name: NameFull: Forrest ML – PersonEntity: Name: NameFull: Huang A – PersonEntity: Name: NameFull: Weir S – PersonEntity: Name: NameFull: Godwin AK – PersonEntity: Name: NameFull: Alhakamy NA – PersonEntity: Name: NameFull: Griffin JD – PersonEntity: Name: NameFull: Berkland CJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2023 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2396-832X Numbering: – Type: volume Value: 8 Titles: – TitleFull: Translational medicine communications Type: main |
| ResultId | 1 |